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Abstract
Background: The pro-apoptotic effector Bid induces mitochondrial apoptosis in synergy with Bax and Bak. In response to
death receptors activation, Bid is cleaved by caspase-8 into its active form, tBid (truncated Bid), which then translocates to
the mitochondria to trigger cytochrome c release and subsequent apoptosis. Accumulating evidence now indicate that the
binding of tBid initiates an ordered sequences of events that prime mitochondria from the action of Bax and Bak: (1) tBid
interacts with mitochondria via a specific binding to cardiolipin (CL) and immediately disturbs mitochondrial structure and
function idependently of its BH3 domain; (2) Then, tBid activates through its BH3 domain Bax and/or Bak and induces their
subsequent oligomerization in mitochondrial membranes. To date, the underlying mechanism responsible for targeting tBid
to mitochondria and disrupting mitochondrial bioenergetics has yet be elucidated.
Principal Findings: The present study investigates the mechanism by which tBid interacts with mitochondria issued from
mouse hepatocytes and perturbs mitochondrial function. We show here that the helix aH6 is responsible for targeting tBid
to mitochondrial CL and disrupting mitochondrial bioenergetics. In particular, aH6 interacts with mitochondria through
electrostatic interactions involving the lysines 157 and 158 and induces an inhibition of state-3 respiration and an
uncoupling of state-4 respiration. These changes may represent a key event that primes mitochondria for the action of Bax
and Bak. In addition, we also demonstrate that tBid required its helix aH6 to efficiently induce cytochrome c release and
apoptosis.
Conclusions: Our findings provide new insights into the mechanism of action of tBid, and particularly emphasize the
importance of the interaction of the helix aH6 with CL for both mitochondrial targeting and pro-apoptotic activity of tBid.
These support the notion that tBid acts as a bifunctional molecule: first, it binds to mitochondrial CL via its helix aH6 and
destabilizes mitochondrial structure and function, and then it promotes through its BH3 domain the activation and
oligomerization of Bax and/or Bak, leading to cytochrome c release and execution of apoptosis. Our findings also imply an
active role of the membrane in modulating the interactions between Bcl-2 proteins that has so far been underestimated.
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Introduction
Over the past 15 years, it has become unequivocally clear that
mitochondria play a crucial in the execution of apoptosis
(Kroemer et al. 1995; Wang 2001). Most pro-apoptotic stimuli
require a mitochondria-amplificatory step, which involves the
disruption of the mitochondrial membrane potential (Vayssie `re et
al. 1994; Petit et al. 1995; Zamzami et al. 1995b; Zamzami et al.
1995a) and the permeabilization of the mitochondrial outer
membrane (MOMP) to apoptogenic factors, such as cytochrome c
and Smac. Release of these factors into the cytosol triggers
different cellular programs that culminate with the activation of
caspases, committing cells to death. MOMP is tightly regulated by
the proteins of the Bcl-2 family, which are divided into three
subfamilies according to their function and homology shared
within four Bcl-2-homology domains (designated BH1-4). The
anti-apoptotic members (e.g., Bcl-2 and Bcl-XL) contain all four
BH domains and repress the release of apoptogenic factors from
mitochondria. In contrast, pro-apoptotic members promote
MOMP and are subdivided into two groups: the multi-domains
proteins (e.g., Bax and Bak) containing the 3 domains BH1-3 and
the BH3 only proteins (e.g., Bid, Bad and Bim) [1]. Bcl-2 and Bcl-
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groove on their surface that can bind to the BH3 domain of the
pro-apoptotic members, thereby neutralizing their action [2,3].
The ability of the Bcl-2 proteins to hetero-dimerize among
themselves provides the basis for the ‘‘life/death’’ rheostat [4]. In
response to death signals, Bax and Bak are activated, directly and/
or indirectly [5,6], by the BH3-only proteins and undergo
conformational changes that result in their stable insertion and
subsequent oligomerization in the mitochondrial outer membrane
[7,8]. The BH3 only protein Bid relays the apoptotic signal from
the extrinsic death receptors to the mitochondria in type II cells
[9]. Following death receptor activation, Bid is cleaved by caspase-
8 into its active form tBid, which rapidly translocates from the
cytosol to the mitochondria and triggers cytochrome c release
[10,11]. Importantly, tBid interacts with mitochondria at the
contact sites between the inner and outer membranes via a specific
binding to cardiolipin (CL) [12,13]. The pro-apoptotic activity of
tBid was first thought to be solely limited to its BH3 domain by
activating Bax and Bak. However, accumulating evidences
strongly indicate that tBid can signal apoptosis through BH3-
independent mechanisms. tBid interacts with CL and induces a
remodeling of the mitochondrial cristae independently of its BH3
domain [14,15,16]. Furthermore, we previously shown that
binding of tBid to CL immediately inhibit ADP-stimulated
respiration and phosphorylation rate independently of Bax and
Bak (Gonzalvez et al. 2005a; Gonzalvez et al. 2005b). Notably,
both cristae remodelling and perturbations of mitochondrial
homeostasis occured in a similar time scale, suggesting that tBid
affects mitochondrial inner membrane in a BH3-independent
manner [13,14]. In line with this, we showed that tBid interacts
specifically interacts with CL monolayers and stabilizes them into
microdomains [13]. Interestingly, CL was recently shown to also
provide an anchor and an activating platform for caspase-8 on
mitochondria essential for efficient Fas signalling in type II cells
[17]. Thus, the localized activity of caspase-8 may ensure that the
cleavage of Bid is accomplished where it is needed, on the surface
of mitochondria.
The structures of Bcl-XL (Muchmore et al. 1996), Bcl-2 (Petros
et al. 2001), Bax (Suzuki et al. 2000) and Bid (Chou et al. 1999;
McDonnell et al. 1999) have been solved. Despite having opposing
roles, these proteins present a similar three dimensional structure
consisting of 6 to 8 amphipathic alpha helices folded into a
globular domain [2]. However, in contrast to Bcl-2, Bcl-XL and
Bax, Bid does not contain a hydrophobic transmembrane domain
at its c-terminus [18]. Bid consists of eight a-helices (designated
aH1 through aH8, respectively), of which aH3 contains the BH3
domain [19,20]. Helices aH6 and aH7 are hydrophobic and form
an anti-parallel hairpin structure that is surrounded by the six
other amphipathic a-helices. Although the underlying mechanism
responsible for the translocation of tBid to mitochondria has been
investigated in the past, conflicting results have emerged and some
clarification is still required. On one hand, targeting of tBid to
mitochondria was shown to rely on post-translational myristoyla-
tion modifications at the N-terminal of tBid [21]. In contrast, other
studies indicated that tBid does not required its N-terminal
myristoylation sites to bind to mitochondria, but relies on a CL
binding domain, consisting of either helices aH4, aH5 and aH6
[12] or aH6, aH7 and aH8 [22,23,24].
In this study, we show that the helix aH6 is responsible for
targeting tBid to mitochondrial CL and disrupting mitochondrial
bioenergetics. In particular, aH6 interacts with mitochondria
through electrostatic interactions involving the lysines 157 and 158
and immediately induces an inhibition of state-3 respiration and a
slight uncoupling of state-4 respiration. These changes may
represent a key event that primes mitochondria for the action of
Bax and Bak. In addition, we also demonstrate that tBid required
its helix aH6 to efficiently induce cytochrome c release and
apoptosis. Altogether, these results strongly support the impor-
tance of the interaction of the helix aH6 with CL for both
mitochondrial targeting and pro-apoptotic activity of tBid.
Results
aH6 Is Necessary for Targeting tBid to the Mitochondria
In order to identify the domain responsible for targeting tBid to
mitochondria, we performed a computer-based analysis of the
biophysical properties of tBid (Figure 1A, 1B and Table 1). The
Kyte-Doolittle hydropathy profile indicated that aH6 was the
more amphiphilic helix of tBid with a hydophibicity of 1.265 and a
net charge of 2.5, and per se the best candidate for a mitochondrial
targeting domain (Figure 1A and B, Table 1).
Thus, we generated deletion mutants of tBid-EYFP (Figure 1C)
and determined the ability of these mutants to translocate to the
mitochondria by fluorescence microscopy and microspectrofluro-
metry (Figure 1D, 1E, and Table 2). CV-1 cells transfected
with tBid-EYFP construct show a punctate staining pattern that
totally overlayed with the mitochondrial-specific stain TMRE
(Figure 1D, a to c). Interestingly, deletion of aH6 completely
abrogated the mitochondrial localization of tBid resulting in a
diffuse cytosolic pattern throughout the cell (Figure 1D, d to f).
These observations were confirmed by microspectrofluorometry
(Figure 1E and Table 2). In CV-1 cells transfected with tBid-
EYFP, EYFP and TMRE fluorescent peaks were of same intensity
indicating that tBid was exclusively mitochondrial (Ratio=1)
(Figure 1E, central panel). Deletion of the alpha helices aH3,
aH4, aH5, aH7 or aH8 did not affect the ratio between those two
peaks, and thus localization of tBid to mitochondria (Table 2). In
contrast, deletion of aH6 decreased the EYFP peak and led to a
two folds decrease in peak ratio (0.53) (Figure 1E, bottom
panel). These resullts strongly indicated that tBid depends on its
helix aH6, and not on its BH3 domain, for its mitochondrial
localization. In line with this, inactivation of the BH3 domain
(tBidE94G) did not affect the ability of tBid to translocate to the
mitochondria (Table 2). Moreover, while single deletion of aH7
and aH8 did not affect the targeting of tBid to mitochondria,
deletion of those helices together with aH6 further decreased the
peak ratio to 0.27 (Table 2), suggesting that aH6–8 may
constitute the mitochondrial-binding domain of tBid. Consitent
with this, aH6–8-GFP localized to mitochondria to the same
extent as the full-length tBid-EYFP (Table 2).
aH6 Recapitulates the Effect of tBid on Mitochondrial
Bioenergetics
We previously showed that tBid inhibits ADP-stimulated
respiration and phosphorylation rate independently of its BH3
domain [13]. Since aH6 was the only helix of tBid required for its
mitochondria localization, we investigated whether aH6 recapit-
ulates the effect of tBid on mitochondrial function. Purified aH6
was added on mice liver mitochondria and the basic bioenergetic
properties of these mitochondria [oxidation rate (Voxidation) and
mitochondrial membrane potential (DYm)], were determined as
described previously [13].
Like tBid [13], addition of aH6 on isolated mitochondria
immediately increased state-4 respiration (to 120% of the initial
state-4 respiration) and inhibited state-3 respiration (by approxi-
mately 25 to 30%) (Figure 2A and 2B). Inhibition of state-3
respiration was further amplified after a second addition of aH6
(5 mM). Importantly, aH6 also inhibited the uncoupling effect of
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PLoS ONE | www.plosone.org 2 February 2010 | Volume 5 | Issue 2 | e9342Figure1.ThehelixaH6targetstBidtothemitochondria.(A)and(B)Computer-basedanalysisofthebiophysicalpropertiesofBid.(A)Kite&Doolittle
profile of Bid (PROSTCALE, Swiss Institute of Bioinformatics). (B) Comparison of the isoelectric points (pI), hydrophobicities and charges of tBid, aH6 and
aH6m.(C)Schematic representationoftBid-EYFPmutants.(D)and(E) CV-1 cellsweretransfectedwith plasmidsendodingtBid-EYFPmutantsin presenceo f
10 mM of Bok-D to inhibit caspases activation and subsequent cell death. 24 h later, cells were stained with 20 nM of the mitochondrial potential probe
TMRE and the localization of the tBid-EYFP mutants was determined using confocal microscopy (D) and microspectrofluorometry analysis (E).
doi:10.1371/journal.pone.0009342.g001
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ing that aH6 affected the electron transport chain (Figure 2B). As
shown in Figure 2D, the effect of aH6 on mitochondrial potential
and respiration is intermediate to those induced by the uncoupler
mClCCP and the complex II inhibitor malonate. This suggests
that aH6 induced bothuncoupling and inhibition of mitochondrial
respiration. Importantly, aH6 had similar effects on mitochondria
isolated from mice overexpressing Bcl-XL and Bcl–2.
The findings that tBid specifically interacts with negatively
charge mitochondrial CL [12], together with the observation that
aH6 binds to mitochondria independently of its hydrophobicity
[22] strongly suggested the involvement of electrostatic interaction.
Notably, aH6 contains two highly conserved lysines at positions
157 and 158 [25]. Therefore, we asked whether these two lysines
could be involved in electrostatic interactions with mitochondria.
To test this, we synthesized a mutant form of aH6 (aH6m), in
which the lysines 157 and 158 were replaced by two alanines
(Figure 1B). This resulted in a loss of two positives charges but
did not affect the hydrophobicity of the helix (Table 1). Mutation
of these lysines completely abrogated the effect of the helix on
mitochondrial bioenergetics, suggesting that aH6 required elec-
trostatic interactions to interact with mitochondria (Figure 2C).
However, mutation of the lysines 157 and 158 did not affect the
mitochondrial localization of tBid (tBidKK157158AA, Table 2). This
may account for the fact, that the helices aH7 and aH8 of tBid,
which present a charge of +0.5 and +3 respectively, can engage
electrostatic interactions with mitochondria (Table 1).
Altogether, these results show that aH6 recapitulates the effect
of tBid on mitochondrial bioenergetics: aH6 interacts with
mitochondria through electrostatics interactions and inhibits
oxidative phosphorylation.
aH6 Inserts into CL Monoloyer through Electrostatic
Interactions and Destabilizes Them into Microdomains
We previously shown that tBid interacts specifically with
artificial CL monolayers and stabilizes them into microdomains
[17]. Using the same biophysical approach, we analyzed the ability
of aH6 to interact with two differents CLs molecular species: (a) a
natural Bovine Heart CL (BHCL), which contains mainly
unsaturated acyl chains of linoleic acid (C18:2), and (b) Tetra-
Myristoylated CL (TMCL), a synthetic molecule which carries
saturated myristoic acids (C14:0).
Monolayers of zwitterionic DPPC (dipalmitoylphosphatidylcho-
line) and negatively charged cardiolipin (BHCL and TMCL) were
spread at an initial surface pressure of 20 mN/m. Addition of aH6
into the lipid subphase significantly increased their surface
pressure (Dp), indicating that aH6 inserted into those lipid
monolayers (Figure 3A). Of note, this insertion was twice more
important in presence CL monolayers and was completely
inhibited after mutation of the lysines 157 and 158.
We then asked whether the interaction of aH6 with CL affect
the organization of the phospholipid monolayer using epifluores-
cence microscopy. Before injection of aH6 into the subphase, lipid
monlayers were in liquid-expanded phase and showed a uniform
bright fluorescence. Addition of aH6 promoted the transition of
the lipid monolayer to the liquid-condensed phase, as indicated by
the appearance of dark probe-excluded domains. These domains
were more rapidly formed in CL than DPPC monolayer and
aH6m did not affect the organization of the phospholipid
monolayer (Data not shown). Therefore like tBid, aH6 inserts
specifically into cardiolipin monolayer through electrostatic
interactions and stabilizes them into microdomains.
aH6 and BH3 Domains Are Both Required for
tBid-Mediated Apoptosis
Since we showed that aH6 is required for targeting tBid to the
mitochondria and recapitulates the effect of tBid on mitochondrial
functions, we asked whether aH6 could also induce apoptosis. We
electroporated aH6-FITC and aH6m-FITC peptides into J. Jhan
Table 1. Biophysical properties of Bid and its alpha-helices:
number of amino acids (AA), isolelectric point (pI),
hydrophobicity and charge.
Names AA number pI Hydrophobicity Charge +/2
Bid Full-length 193 5,27 20,488 26,5
Bid N-ter 60 8,36 20,579 +3
H3 21 5,57 20,848 20,5
H4 10 10,55 +0,930 +1
H5 18 3,90 21,094 23
H6 18 10,50 +1,265 +2.5
H7 14 7,55 20,057 +0,5
H8 10 12,2 21, 000 +3
H6m 18 7,56 +1,456 +0,5
H6 + K H7 27 9,99 +0,807 +3
H6 + H7 35 9,99 +0,650 +3
H6 + H7 + H8 47 10,93 +0,212 +5
H4 + H5 + H6 58 9,19 20,340 +1,5
BH3 Domain 25 7,55 20,596 20,5
Other constructs like the hairpin forming domain aH6–H7 domain are
described. The calculation of hydrophobicity was performed using the
PROTSCALE software from the Swiss Institute of Bioinformatics according to the
method of Kyte and Doolittle. aH6 and aH6m are presented in italic.
doi:10.1371/journal.pone.0009342.t001
Table 2. Intracellular localization of Bid-EYFP, tBid-EYFP and
its deletion mutants.
Construct EYFP/TRME Localization
tBid 160,07 Mitochondrial
tBidE94G 160,07 Mitochondrial
tBidDBH3 160,07 Mitochondrial
tBidDH6 0,5360,05 Cytoplasmic
tBidDH6–H7 0,3060,03 Cytoplasmic
tBidDH6–8 0,2760,03 Cytoplasmic
tBidDBH3DH6–8 0,2760,03 Cytoplasmic
tBidKK157,158AA 0,9460,40 Mitochondrial*
tBidE94G,KK157,158AA 0,9460,54 Mitochondrial*
tBidDH3, or DH4, or DH5, or DH7, or DH8 0,9760,09 Mitochondrial
CV-1 cells were transfected with plasmids encoding Bid-EYFP, tBid-EYFP or tBid-
EYFP mutants in presence of 10 mM of Bok-D. 24 h later, cells were stained with
20 nM of the mitochondrial potential probe TMRE and the localization of the
tBid-EYFP mutants was determined by calculation of the TMRE/EYFP ratios
using microspectrofluorometry. A ratio of 1.0 indicates that EYFP exclusively
colocalizes with TMRE at the mitochondria while a lower ratio indicates that
EYFP is also localized to the cytosol. The * highlights the contructs that localize
to the mitochondria but are unable to induce cytochrome c release or to alter
mitochondrial bioenergetics. The constructs that localize to the cytoplasm are
in italic.
doi:10.1371/journal.pone.0009342.t002
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PLoS ONE | www.plosone.org 4 February 2010 | Volume 5 | Issue 2 | e9342Figure 2. The helix aH6 affects mitochondrial bioenergetics. Purified mice liver mitochondria (M) were incubated in respiratory buffer
(0.33 mg/ml). Oxygen consumption (Voxidation, black line) and mitochondrial potential (DYm, bleu line) were monitored using a Clark-type
electrode coupled to a tetraphenylphosphonium (TPP
+) cation-sensitive electrode, as described previously [13]. 10 mM of succinate was added as
oxidizable substrate (malonate is 1 mM). ADP was added to 110 mM and mCCCP was added to 10 mM. The numbers along the traces gives the values
of oxidation rates in nmol O2/min/mg protein (Black) and mitochondrial potential in mV (Blue) (A) Oxygen consumption and potential of
mitochondria oxidizing succinate. (B) and (C) Effect of the addition aH6 and aH6m on the oxygen consumption and mitochondrial potential. Each
panels (A), (B) and (C) is representative of 3 independent experiments. (D) Representation of the effect of aH6 on oxidation rate and potential of
mitochondria isolated from control, Bcl-2 and Bcl-XL transgenic mice, as compared to uncoupling and inhibition of the mitochondrial respiration.
Dotted black line shows the effect of the uncoupler CCCP, and the solid black line represents the inhibition of succinate-respiration by the specific
inhibitor of complex II, malonate.
doi:10.1371/journal.pone.0009342.g002
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potential, caspase activation and cell viability by flow cytometry
(Figure 4). Upon electropermeabilization, 90% of the viable cells
incorporated aH6-FITC or aH6m-FITC (Figure 4A, left and
middle panel). Consistent with our previous observations, only
mitochondria isolated from cells electroporated with aH6-FITC
exert a FITC-fluorescence (Figure 4A, right panel).
Electropermeabilization of aH6 induced a time and dose-
dependent induction of apoptosis characterized by a drop of
mitochondrial potential, activation of the effector caspase-3 and 7,
PARP cleavage, externalization of phosphatidyl serine
(Figure 4B–D). In contrast, electropermeabilization of aH6m
did not lead to apoptosis (Figure 4B–D). To further confirm these
results, we micro-injected aH6 and aH6m peptides into Jurkat
cells (Figure 4F). As expected, micro-injection of 2.5 mMo faH6
induced blebbing of the cells after 4 hours, while aH6m had no
effect. Notably, 2.5 mMo faH6 induced membrane blebbing with
a similar kinetics as 5 nM of tBid.
By comparing the dose response curves of caspase 3/7
activation induced by electropermeabilized recombinant tBid
and aH6 peptide (Figure 4D), it appeared that tBid is efficient
at nM doses, while aH6 peptide showed an effect at mM range of
concentrations. Interestingly, fusion of BH3 domain peptide to
aH6 peptide strongly increased the activity of the peptide and
shifts the effective dose to nM range. This suggested that both BH3
and aH6 domains may participate in the pro-apoptotic activity of
tBid.
To determine the importance of both BH3 and aH6 domains
for tBid-induced apoptosis, we compared the pro-apoptotic
activity of tBid-EYFP constructs in HCT116 cells by monitoring
mitochondrial membrane potential and cell viability (Figure 5A).
While full length tBid-EYFP induced mitochondrial membrane
depolarization in 88% of cells and lead to more than 80% of cell-
death, single deletion of BH3 or aH6 domains strongly inhibited
tBid-mediated apoptosis. Therefore, tBid relies on both BH3 and
aH6 domains to induce apoptosis. We then took advantage of the
Bax or Bak knock-out and double knock-out DKO MEFs cells to
investigate the involvement of Bax and Bak in tBid-mediated
apoptosis. Transfection of tBid in wild type, Bax-deficient or Bak-
deficient MEFs incuced mitochondrial depolarization after
8 hours (Figure 5B). In contrast, DKO MEFs were strongly
protected from tBid-induced apoptosis at this time point (red
arrow) (Figure 5B). Consistent to our previous findings, tBidDH6
did not induce apoptosis in MEFs. Importantly, tBid was able to
induce mitochondrial potential depolarization and to kill DKO
MEFs at latter time point, reaching 70% of cell death after
62 hours (Figure 5C). This may account for mitochondrial
bioenergetic alteration and lipid peroxidation induced by the aH6
domains of tBid (data not shown). In line with this, deletion of aH6
completely protected the DKO MEFs from t-Bid mediated
apoptosis whereas deletion of the BH3 domain had no effect.
We previously showed that tBid is able to induce cytochrome c
release via a BH3-independant mechanism involving transient
opening of the PTP (permeability transition pore) [17]. Therefore,
we next analyzed the role of the BH3 and aH6 domain in tBid-
mediated cytochrome c release. Addition of recombiant tBid on
isolated mitochondria resulted in a time-dependant release of
cytochrome c, which reach 70% of the total cytochrome c after 30
minutes (Figure 6). As we expected from the lack of mitochon-
drial localization, deletion of aH6 strongly impaired the
cytochrome c release activity of tBid (20% after 30 min).
Importantly, inactivation of the BH3 domain (tBid G94E) or
mutation of the two lysines 157 and 158 (tBid KKAA) had similar
inhibitory effect on tBid-mediated cytochrome c release (40% after
Figure 3. The helix aH6 specifically inserts into CL-monolayers
through electrostatic interactions and reorganizes them into
microdomains. Dipalmitoylphosphatidylcholine (DPPC), bovine heart
CL (BHCL) and tetramyristoyl CL (TMCL) were spread at an initial surface
pressure of 20 mN/m. aH6 and aH6m (1 mM) were injected into the
subphase of these lipids monolayers. (A) The surface pressure changes
(B) and epifluorescence images (C) were recorded as described
previously (Gonzalvez et al 2005, CDD).
doi:10.1371/journal.pone.0009342.g003
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PLoS ONE | www.plosone.org 6 February 2010 | Volume 5 | Issue 2 | e9342Figure 4. Electroporation and microinjection of aH6 induces apoptosis in Jurkat cells. Jurkat cells were electroporated with 2.5 mMo f
aH6-FITC and aH6m-FITC peptides, as described previously (Gabriel 2003). The efficiency of peptides electroporation into these cells was determined
by measuring the FITC fluorescence using flow cytometry (A). Mitochondria were isolated from these cells, and analyze by flow cytometry described
previously [36]. (B and C) Effect of aH6 and aH6m electroporation (2.5 mM) on mitochondrial potential, caspases 3/7 activation and cell viability in
Jurkat cells. (B) Left panels: dot plot of DIOC(6)3 vs PI staining cells. Right panels: caspases 3/7 activities by cleavage of the Phiphilux substrate. E refers
to electroporated cells. (C) Left pannels: dose response of aH6 and aH6m on mitochondrial potential, caspases 3/7 activation and apoptosis. Right
panels: Caspase-3 and PARP cleavage were analyzed by Western Blotting. (D) Dose response curves of caspases 3/7 activation induced by
electropermeabilization of tBid, aH6-BH3, and aH6 in Jurkat cells. (E) Jurkat cells were microinjected with tBid, aH6 and aH6m and the percentage of
cell blebbing was measured by microscopy (F). Data are representative of 10 independant measurements (n=10).
doi:10.1371/journal.pone.0009342.g004
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substitution of the two lysines (tBidG94E,KKAA) further inhibited the
release of cytochrome c to the level tBidDH6 (20% after 30 min).
This indicated that tBid induces cytochrome c release through
BH3 dependant and BH3-independant mechanisms; the lastest
involving electrostatic interactions through its aH6.
tBid Relies on aH6, but Not on Its BH3 Domain, to
Inducte Superoxide Anion Production and Mitochondrial
Lipid Peroxidation
We have previously shown that tBid inhibits ADP-stimulated
respiration and phosphorylation rate in isolated mitochondria
through a BH3 independent mechanism in mice and yeast
mitochondria [13]. Here, we investigated whether tBid affects
cellular bioenergetics. Electroporation of tBid in hepatocytes lead
to a decrease in cellular NADP(H) fluorescence associated with an
acidification of the cytosol, while tBidDH6 or tBid KK157,158AA
had no effect (Figure 7A and 7B).
We examined whether tBid enhances superoxide anion
production and lipid peroxidation in AtT20 cells. Transfection
of tBid induced superoxide anion production in 60% of the cells
(Figure 7C, upper panel). Deletion of aH6 or mutation of the
lysines 157 and 158 completely abrogated the induction of
superoxide anion in AtT20 cells. In contrast, deletion of the BH3
domain slightly decreased superoxide production. In line with this,
tBid induced superoxide anion in Bax and Bak DKO MEFs cells
(Figure 7C, lower panel). We also measured ROS (reactive
oxygen species) production in purified mice liver mitochondria
(Figure 7D). Addition of succinate to energize the mitochondria
did not affect ROS level (superoxide anion and hydroperoxide)
and inhibition of the electron transport chain using antimycin A
strongly induced the production of ROS by mitochondria.
Importantly, addition of tBid or the helix aH6 on isolated
mitochondria increased ROS production in a similar manner. As
expected, aH6m had no effect on mitochondrial ROS level.
Finally, we analyzed the effect of tBid and aH6 on
mitochondrial lipid peroxidation in permeabilized-hepatocytes
(Figure 7E). Addition of 10 nM of tBid induced mitochondrial
lipids peroxidation, similar to the effect obtained after treatment
with anti-Fas antibody and TNFa plus cycloheximide. Consistent
Figure 5. aH6 and BH3 domains are both required for tBid-induced apoptosis. (A) Jurkat cells were transfected with either empty vector
control or with plasmids encoding tBid, tBidDBH3 and tBidDH6. 12 h latter mitochondrial membrane potential DYm (TMRE) and cell viability (PI)
were assessed by FACS analysis. Each panels is representative of 3 independent experiments. (B) Wild-type, Bax
+/+, Bax
2/2, Bak
2/2 or double-
knockout (DKO) Mefs cells were transfected with either empty vector control or with plasmids encoding tBid and tBidDH6. After 8 h, green cells were
analyzed by FACS for mitochondrial potential using TMRE. The red arrow indicates the DYm in DKO Mefs. (C) Mefs cells were transfected with
plasmids encoding tBid and tBidDBH3, and the kinetics of mitochondrial depolarization and cell death were measured over 60 h by FACS analysis.
doi:10.1371/journal.pone.0009342.g005
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mitochondrial lipid peroxidation. Mitochondrial lipid peroxida-
tion was partially inhibibited by pre-treating the hepatocytes with
the antioxidants, Trolox and MnTBAP [Mn(III)tetrakis(4-benzoic
acid) porphyrin chloride], and completely inhibited using the
mitochondrion-specific antioxidant, mitoQ10 (Figure 7E).
Thus, tBid relies on its aH6 helix, but not on its BH3 domain, to
inducte superoxide anion production and mitochondrial lipid
peroxidation.
Discussion
We have previously shown that tBid disrupts mitochondrial
bioenergetics independently of its BH3 domain [13]. Here, we
identify the helix aH6 as the domain responsible for targeting
tBid to mitochondrial CL and disrupting mitochondrial
bioenergetics.
We show here for the first time, that the helix aH6 interacts
with mitochondria through electrostatic interactions involving the
lysines 157 and 158 and recapitulates the effect of tBid on
mitochondrial bioenergetics. Binding of aH6 leads to an inhibition
of ADP-stimulated respiration (state 3 respiration) associated with
a slight uncoupling of state-4 respiration. This is consistent with
the findings by Liu et al. [15] that showed the ability of the Bid’s
‘‘putative cardiolipin-binding domain’’, containing aH6, to affect
mitochondrial respiration. Biophysical analyses revealed that, like
tBid [13], aH6 binds specifically to CL-enriched lipid monolayers
via electrostatic interactions and reorganized them into micro-
domains. These results, together with our previous report [13],
strongly indicate that tBid interacts with mitochondrial contact
sites through electrostatic interaction involving its helix aH6 with
CL. In parallel, we also demonstrated that tBid required its helix
aH6 to induce the production of mitochondrial ROS and to
promote mitochondrial lipid peroxidation. Thus, interaction of
tBid with CL may lead to the reorganization of the mitochondrial
phospholipids into microdomains, and affect the activity the
enzymes involved in mitochondrial functions resulting in ROS
production and mitochondrial lipid peroxidation.
Moreover, electrostatic interaction of aH6 with mitochondria
leads to the release of cytochrome c and subsequent caspase
activation and apoptosis. Of note, mutation of the lysines 157 and
158 did not affect the mitochondrial localization of tBid but
inhibited tBid-cytochrome c release activity. This strongly supports
a role of aH6 in this process. In line with this, we showed that tBid
relies on its aH6 to induce apoptosis.
Importantly, while tBid does not rely on its BH3 domain to
translocate to mitochondria and to inhibit mitochondrial function,
the BH3 domain is required for the ability of tBid to efficiently
induce cytochrome c release and apoptosis. This is in aggrement
with previous studies showing that tBid interacts with mitochon-
dria in Bax and Bak independent manner [17,27,28] and rules out
the possibility these two proteins act as putative receptors for tBid
at the mitochondrial surface. Altogether, these results indicate that
tBid induces apoptosis via a BH3-dependant mechanism involving
Bax and Bak and via a BH3-independant mechanism involving
electrostatic interactions within its aH6.
Based on these observations, we proposed a two steps model for
the pro-apoptotic activity of tBid (Figure 8). First, tBid binds to
CL present at the mitochondrial contact sites via its helix aH6 and
destabilizes mitochondrial functions, resulting in cytosolic acidifi-
cation, ROS production and mitochondrial lipid peroxidation.
This environment may prime the activation of Bax and/or Bak.
Notably, hydrogen peroxide-mediated acidification of the cytosol
has been shown to promote the translocation of Bax to the
mitochondria [29]. Then, tBid interacts through its BH3 domain
with Bax/Bak to promote their oligomerization and subsequently
induce cytochrome c release and apoptosis. We believe that our
results provide new insights into the mechanism of action of tBid
on the mitochondria and strongly support the importance of
protein-lipid interaction, and in particular of the helix aH6 with
CL, in this process.
Materials and Methods
Materials
All chemicals and supplies were obtained from Sigma (St. Louis,
MO, USA) unless otherwise stated. Full-length His-tagged wild-
type and mutant mouse Bid were purified as described by
Desagher et al. [30].
Stock solutions of tBid (1.9 mg/ml) were diluted to nM
concentrations in respiratory buffer. Buffer alone had no effect
on mitochondrial parameters.
Animals
We used 6- to 12-week-old, age- and sex-matched congenic
mice, expressing a Bcl-2 [31] or Bcl-xL transgene [32] under the
L-type pyruvate kinase gene promoter. Bax
2/2 and Bak
2/2 mice
(kindly provided by Craig.B. Thompson and Stanley Korsmeyer,
USA) were also used. C57/Bl6 mice were used as controls and for
hepatocytes or mitochondrial preparations.
Peptides Synthesis
Peptides were synthesized by Covalab (Lyon, France) on a
Rainin Symphony synthesizer by a standard SPPS (solid phase
peptide synthesis) method (Novabiochem). The peptides were
purified by HPLC, and the identity and purity of the peptides were
confirmed by mass spectroscopy and by amino acid analysis.
The Bid-BH3 peptide was synthesized with the sequence
RNIARHLAQVGDSMDR. Nontoxic concentrations (less than
5 mM) of this peptide were added to mitochondria from Bax/Bak
DKO cells. The sequence of the principal helix, aH6, was
EKTMLVLALLLAKKVASH; that of its mutated counterpart,
Figure 6. aH6 and BH3 domains are both required for tBid
cytochrome c release activity. (A) and (B) Jurkat cells were
electroporated with plasmids encoding tBid, tBidDH6, tBidG94E,
tBidKKAA and tBidG94EKKAA and the kinetics of cytochrome c release
in the cytosolic fractions were detected by ELISA.
doi:10.1371/journal.pone.0009342.g006
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PLoS ONE | www.plosone.org 9 February 2010 | Volume 5 | Issue 2 | e9342Figure 7. tBid required its helix aH6, but not its BH3 domain, to induce superoxide anion production and mitochondrial lipid
peroxidation. (A) and (B) Wild-type hepatocytes were transfected with a control vector (control) or plasmids encoding tBid, tBidDH6, tBidDBH3 and
tBidKKAA and NAD(P)H and SNARF-1AM fluorescence (pH indicator) were measured by FACS. Data are given as % of the control 6 SD. pH units were
determined using a calibration curve generated using nigericin-permeabilized cells kept in buffer of different pH values. (C) AtT20 cells or DKO Mefs
were transfected with empty vector (control) or plasmids encoding tBid, tBidDH6, tBidDBH3, tBid tBidKKAA, tBidDH6–H7, tBidDBH3DH6H7. Cells were
then stained with hydroethidine (HE, Invitrogen/Molecular probes) to measure superoxide anion production. The percentages of transfected cells are
indicated by the dotted line. (D) Purified mice liver mitochondria were energized using succinate (+ rotenone) and treated using 10 nM tBid, H6-5G-
BH4, aH6 and aH6m. Mitochondrial superoxide anion production was measured using HE (a.u. = arbitrary units) whereas hydroperoxide was
measured using amplex red. (E) Wild-type hepatocytes were treated with TNFa/cycloheximide, anti-Fas antibody or transfected with a plasmids
encoding tBid and tBidDH6. Mitochondrial lipid peroxidation was measured by FACS using MDA. We used the antioxidants trolox (2 mM), MnTBAP
(1 mM) and MitoQ10 (1 mM).
doi:10.1371/journal.pone.0009342.g007
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toxicity of the Bid-BH3 peptide and others was tested on purified
mitochondria, using the same protocol as for tBid (see below). A
Bid-BH3 peptide linked by five glycine residues to H6 was also
constructed (EKTMLVLALLLAKKVASH-GGGGGRNIA
RHLAQVGDSMDR) and purified to test the efficiency of the
BH3 peptide linked to an effector involved in the disruption of
mitochondria, namely aH6. All peptides synthetized have an
helicoidal alpha structure when membranes containing CL are
present. Number of amino acids (AA), isolectric point (pI),
hydrophobicity and charge were calculated for tBid and the
aH6 and aH6m peptides (Table 1).
The calculation of hydrophobicity was performed using the
PROTSCALE software from the Swiss Institute of Bioinformatics
(http://www.expasy.org/tools/protscale.html) according to the
method of Kyte & Doolittle [33]. All tBid constructs used in this
study are described in Figure 5A. They are named tBid,
tBidDBH3, tBidDH3–5, tBidDH6, tBidDH6–7, tBidDH6–8,
tBidDBH3DH6, tBidDBH3DH6–7, tBidKK157,158AA, tBidE94G
and also tBidE94G,KK157,158AA (all the constructs are described in
Figure 1C exept tBidDH3, tBidDH4 and tBidDH5). Mef Bax
2/2,
Bak
2/2 and DKO (Bax
2/2, Bak
2/2) cells were kindly provided
by Stanley Korsmeyer, Dana Farber Institute, Boston, MA, USA.
DNA Constructs
Full-length Bid cDNA was obtained from HL-60 cells by RT-
PCR and subcloned into pCR2.1 vector from Stratagene, Inc (La
Jolla, CA, USA). Oligonucleotide primers (Operon Technologies,
Alameda, CA, USA) were designed to amplify the C-terminus of
Bid (tBid) and deletion mutants by PCR with Bid cDNA as the
starting template. Deletion mutants were based on the 3D
structure in solution [19,20]. These PCR products were then
subcloned into pGEX-4T-1 (Qiagen, Inc, Alameda,Ca, USA), a
GST-fusion vector.
Transfections
The tBid-EYFP deletion mutants were transiently introduced
into AtT20 or CV-1 cells with Lipofectamine 2000
TM (Invitrogen
SARL, Cergy Pontoise, France). Cells were seeded one day before
transfection. We used 2 mg of plasmid DNA and 10 ml
Lipofectamine 2000
TM for each 6-well plate. Transfected tBid
protein induces a high rate of cell death; thus experiments were
carried out in the presence of 10 mM Bok-D, a very potent
caspase-3 inhibitor, to avoid complete breakdown of the cells
following binding of the protein to the mitochondrial membrane
and cells were shorted on a low level of EYFP before flow
cytometry analysis since higher level linked to overexpression of
the contructs led to a cytotoxic death.
Isolation of Mouse Hepatocytes
Mouse hepatocytes were isolated using a standard protocol [34].
Viable purified hepatocytes were separated from other cells by iso-
density Percoll centrifugation [35] and were resuspended in M199
medium (Gibco-BRL) for immediate use.
Oxygen Uptake, Membrane Potential, Rate of
Phosphorylation and Large Amplitude Swelling
Percoll-purified mitochondria from mouse liver [36] were
resuspended in respiratory medium (R) consisting of 100 mM
KCl, 40 mM Sucrose, 5 mM MgCl2, 10 mM TES, 10 mM
KH2PO4 (pH 7.2), 1 mM EGTA and 0.1% BSA. Mitochondrial
protein concentration was 0.333 mg/ml, for all procedures (in a
3 ml cuvette). Mitochondrial respiration rate (Vox) and membrane
potential (DYm) were monitored by simultaneous use of a Clark-
type electrode, a tetraphenylphosphonium cation-sensitive elec-
trode (TPP
+) and a pH-electrode at 25uC in medium R as
described in Gonzalvez et al. [13]. Trace amounts of EGTA
(10 mM) ensured good experimental reproducibility without
affecting pore opening. When mitochondria are extracted from
cells, the procedure used is that of Gonzalvez et al. [13] and the
mitochondria are resuspended in the medium R as descripbed
above.
In-Vitro Assay of Cytochrome c Release
Purified mitochondria from mouse livers were resuspended in
medium R (pH 7.2). Isolated mitochondria (5 mL; stock concen-
tration 25 mg/mL) in medium S were gently stirred for 30 min at
room temperature with the indicated amount of proteins or
reagents in the presence of protease inhibitor cocktail (4 ml)
(Sigma) in a final volume of 50 mL. Mitochondria were then
collected by centrifugation at 12,000 g for 5 min at 4uC;
Figure 8. tBid, a bifunctional molecule. (A) Current model of the
BH3-dependant function of tBid. tBid interacts through its BH3 domain
and directly activates Bax, which undergoes conformational changes
that induce the exposure of its N-terminal domains. This results in the
stable insertion and subsequent oligomerization of Bax in the
mitochondrial outer membrane leading to the release of cytochrome
c and apoptosis. This model highlights the importance of protein-
protein interactions between tBid and Bax. (B) Refined model of the
pro-apoptotic function of tBid: importance of tBid/CL interactions. First,
tBids binds to CL present at the contact sites via its helix aH6 and
destabilizes the mitochondrial membrane. This may affect the activity of
the electron transport chain complexes and lead to an acidification of
the cytosol, mitochondrial ROS production and mitochondrial lipid
peroxidation. This environment may prime the activation of Bax and/or
Bak. Then, tBid interacts through its BH3 domain with Bax and/or Bak to
promote their oligomerization and subsequently induce cytochrome c
release and apoptosis.
doi:10.1371/journal.pone.0009342.g008
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detected with a mouse monoclonal anti-cytochrome c antibody
(Pharmingen, clone 7H8.2C12). In other circonstancies, we used
the ELISA test from.
Biophysical Measurement of Lipid Monolayers
We used the purest quality of DPPC (Dipalmitoylphosphati-
dylcholine) available from Sigma. The sodium salt of bovine heart
cardiolipin (BHCL) was purchased from Sigma and used without
further purification (fatty acid analysis by gas-liquid chromatog-
raphy: 18:2, 92.2%; 18:1, 6.7%; 16:0, 0.5%; 16:1, 0.4%; 18:0,
0.2%). Synthetic TMCL (Tetramyristoyl cardiolipin) (and fluores-
cent probes NBD-PC (2-(6-(7-nitrobenz-2-oxa-1, 3-diazol-4-yl)
amino) hexanoyl -1-hexadecanoyl-sn-glycero-3-phosphocholine)
and NBD-PG (2-(6-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino) hex-
anoyl-1-hexadecanoyl-sn-glycero-3-phosphoglycerol) were ob-
tained from Molecular Probes Inc. (USA.). Stock solutions
(1610
23 M and 2.5610
24 M) were prepared for DPPC in
chloroform and for TMCL or BHCL in 3:1 chloroform/methanol
(v/v). Penetration experiments were carried out in a Teflon dish at
22uC in a thermostatically controlled box. The Teflon dish has a
volume of 10 ml and a surface area of 12.57 cm
2. Phospholipid
monolayers were spread to give the desired initial surface pressure
on a subphase of 150 mM NaCl, 5 mM Tris-HCl (pH 7.5). The
subphase was continuously stirred with a magnetic bar at a slow
rate so as not to disturb the monolayer. The lipid monolayers then
equilibrated for 15 min at various initial surface pressures (pi)
before injection of the helix into the subphase. Peptide was added
to the subphase through a hole in the Teflon chamber. All injected
volumes were #1% of the total subphase volume. The surface
pressure (p) was measured by the Wilhelmy method. Changes in p
were completed 30 min after peptide injection. The maximum
increase in surface pressure (Dp) induced by the adsorption of the
peptide was defined as the difference between the initial pressure
(pi) and the plateau value. The data shown are means from
triplicate measurements and are represented as Dp versus pi.
Epifluorescence Microscopy of Lipid Monolayers
Monolayers were visualized with an Olympus-BX30 micro-
scope set on the Teflon dish. As previously described [37], images
were recorded with an AIS (MXRi2) video camera. These
experiments were carried out at 22uC and pH 5.7. Mixtures were
prepared from a chloroform solution of DPPC or TMCL
containing 0.5 mol% NBD-PC or NBD-PG. The probe is
excluded from densely packed areas of lipid, providing contrast
between lipid phases. Images were recorded at constant area and
as a function of time after the injection of the peptide.
Intracellular Localization of tBid and tBid Constructs:
Acquisition and Image Analysis
Transfected cells (CV-1) were stained with 20 nM TMRE
(tetramethylrhodamine ethyl ester, Molecular Probes, Invitrogen)
for 15 min at room temperature. Images were collected in real time
on a Nikon Eclipse TE 300 DV inverted microscope fitted with an
100X oil objective using appropriate fluorescence emission filters.
Images of EYFP and TMRE (tetramethylrhodamine ethyl ester)
fluorescence were acquired with a back-illuminated cooled detector
(CCD EEV: NTE/CCD-1024-EB, Roper Scientific, France).
NAD(P)H fluorescence was also recorded in order to have a dual-
localization reference; NAD(P)H fluorescence is predominantly
mitochondrial (80%), but is partly (20%) cytoplasmic. NAD(P)H
auto-fluorescence wasmonitored under excitation wavelengthsof340
to 380 nm and emission wavelengths of 435 to 485 nm. Metamorph
software (Universal Imaging Corporation, Roper Scientific, France)
was used for data acquisition. The Image J program (http://rsb.info.
nih.gov/ij/) was used for image processing.
Microspectrofluorometric Analysis
A Zeiss UMSP 80 confocal microscope equipped with an UV-
visible argon laser and an optical multichannel analyzer (OMA III
with an IRY 1024/6B from Princeton Applied Research) was used
for microspectrofluorometric analysis under epi-illumination
conditions. A Prism system (Jobin & Yvon) was used to acquire
and treat data. The excitation wavelength was set to 488 nm. The
spectra were recorded at wavelengths in the 540 nm to 750 nm
range in an 0.8 mm
2 area. Spectra for cytoplasmic EYFP (empty
vector from BD Bioscience, USA) and mitochondrial TMRE were
used as references (Figure 5B).
Electropermeabilization
The J. Jhan human lymphoblastoid CD4
+ T-cell line (derived
from the Jurkat cell line; provided by J.D. Fox, London, England)
was grown at a density of 1610
6 cells per milliliter in RPMI 1640
medium supplemented with 5% (v/v) fetal calf serum, 2 mM L-
glutamine, 100 U/ml penicillin, and 100 mg/ml streptomycin in
5% CO2 at 37uC. All procedures were as described by Gabriel
et al. [26].
Western Blot Analysis
Cells were lysed by incubation with modified Laemmli buffer
(60 mM Tris, pH 6.8, 10% glycerol and 2% sodium dodecyl
sulfate (SDS), without b-mercaptoethanol and bromophenol blue)
and sonicated for 30 s on ice. The lysate was centrifuged at 3000 g
for 5 min. The supernatant was incubated for 5 min at 100uC.
Aliquots of the supernatant were assayed for protein concentration
(Micro-BCA Protein Assay, Pierce Chemical Co., Rockford, IL,
USA). Cell lysate proteins (20 mg per lane) were resolved by 7.5%
and 15% SDS-polyacrylamide gel electrophoresis. Proteins were
then electroblotted onto nitrocellulose filters with 0.45 mm pores;
filters were incubated for 1 h with 5% nonfat milk and 0.1%
Tween 20-containing PBS. The filters were then incubated for 1 h
at room temperature with 1 mg/ml monoclonal anti-caspase-3
rabbit antiserum (Pharmingen, San Diego, CA, USA) or 1 mg/ml
PARP mAb C2.10 (purchased from Dr. Poirier, Quebec, Canada).
Blots were washed three times for 10 min with 0.2% Tween 20-
containing PBS and incubated for 1 h with peroxidase-labeled
anti-mouse or anti-rabbit immunoglobulin (1/5000). Blots were
developed using an enhanced chemiluminescence detection system
(ECL, Amersham Corp., Cardiff, UK).
Flow Cytometry
Changes in mitochondrial membrane potential difference
(DYm) were evaluated by incubating cells (5610
5/ml) for
15 min at 37uC, with DiOC6(3) (stock solution 1 mM in ethanol,
final concentration 2.5 nM). Cells were then analyzed using the
FACScalibur 4 colors cytometer. The fluorescence was collected
for DiOC6(3), after suitable compensation, in FL-1 channel
(530630 nm) NAD(P)H autofluorescence was elicited with an
argon laser (488 nm at 100 mW) and multiline ultraviolet light at
400 mW. Changes in the auto-fluorescence of normal and
apoptotic cells were recorded. The light emitted was collected
with a 424640 nm bandpass for the NAD(P)H fluorescence [38].
The pH within single cells was monitored with the fluorescent pH
indicator 5-(and-6-)-carboxy-seminaphtho-rhodafluor-1 acetoxy
methyl ester acetate (SNARF-1 AM) as described by Petit et al.
[38].
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fluorogenic caspase substrate PhiPhilux G1D2 (OncoImmunin
Inc., Kensington, MD, USA), which contains the GDEVDG
sequence. Briefly, native and electropermeabilized cells were
harvested and washed twice in PBS buffer. Cells were resuspended
in 50 ml of PhiPhilux-containing solution and incubated for 1 h at
37uC in the dark. Then, they were washed and suspended in PBS
buffer and analyzed. Exposed phosphatidylserine (PS) on the
plasma membrane outer leaflet was measured by staining cells
with annexinV-FITC (1 mg/ml) for 10 min at 4uC. AnnexinV-
FITC absorption onto the cell surface was monitored by flow
cytometry (FL-1); membrane integrity was assayed with propidium
iodide (1 mg/ml), which emitted signal in the FL-3 channel (long
pass.670 nm), using standard protocols. A minimum of 5610
3
events were acquired in list mode and analyzed with Cellquest
software (Becton Dickinson).
When the cells are tranfected with tBid vectors, the cells with
low EYFP fluorescence where shorted prior their examination, to
avoid cells with high levels of EYFP in which the high
surexpression of the protein become cytotoxic, regardless of their
physiological properties.
Superoxide Anion and Hydroperoxide Production and
Lipid Peroxidation
Briefly, treated cells were incubated with 2.5 mM dihydroethi-
dium for 15 min at 37uC for superoxide anion production. Cells
were washed and resuspended in phosphate-buffered saline for
flow cytometry. They were then counterstained with 2 mM
TOPRO-3 (1 mg/ml stock solution) to monitor cell viability.
ROS generated by isolated mitochondria were monitored using
the Amplex Red assay for H2O2 (Molecular Probes, Eugene, OR,
USA) [39]. Mitochondria (50 mg protein) were incubated in
standard incubation medium supplemented with 2 mM Amplex
Red, 1 U/mL horseradish peroxidase, and 0.1 mM EGTA in a
400 mL cuvette at 37 C with continuous stirring. Fluorescence
from resorufin, a product of the Amplex Red reaction with H2O2,
was measured in a Perkin-Elmer LS 55 luminescence spectrometer
using excitation/emission wavelengths of 550 and 590 nm,
respectively. Results were expressed as a percentage of H2O2
production with succinate + antimycin A (100%). The generation
of ROS in TNFa, Fas-antibody- or tBid-mediated effects - in
particular, lipid peroxidation - was determined by measuring
malondialdehyde (MDA) formation, a common end product of
lipid peroxidation, with the Lipid Peroxidation Assay Kit (Oxford
Biomedical Research, Oxford, MI). Materials were prepared
according to the manufacturer’s instructions. MDA standards
provided in the kit were used to quantify the amount of MDA
formed.
Experimentation on Vertebrate Animals
* The research involving animals must have been conducted
according to the Directive of 24 November 1986 on the
approximation of laws, regulations and administrative provisions
of the member states regarding the protection of animals used for
experimental and other scientific purposes (86/609/EEC).
* All research involving animals has been approved by ethics
council of the National Center for Scientific Research (CNRS).
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